![Pieter J. Strijkert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pieter J. Strijkert
Chairman at Dynacorts Therapeutics BV
Profile
Pieter J.
Strijkert is currently the Chairman at Janssen Vaccines & Prevention BV and Dynacorts Therapeutics BV.
He was previously the Chairman at Introgene BV and a Director at Chiron Corp., Paratek Pharmaceuticals, Inc., and deVGen NV.
He holds a graduate and doctorate degree from the University of Utrecht.
Pieter J. Strijkert active positions
Companies | Position | Start |
---|---|---|
Dynacorts Therapeutics BV
![]() Dynacorts Therapeutics BV Medical/Nursing ServicesHealth Services Dynacorts Therapeutics BV provides treatments for depression and anxiety disorder. The private company is based in Leidschendam, Netherlands. | Chairman | - |
Janssen Vaccines & Prevention BV
![]() Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Chairman | - |
Former positions of Pieter J. Strijkert
Companies | Position | End |
---|---|---|
Introgene BV | Chairman | 2008-10-22 |
Paratek Pharmaceuticals, Inc. /Old/
![]() Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Director/Board Member | - |
deVGen NV
![]() deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Director/Board Member | - |
Chiron Corp.
![]() Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Director/Board Member | - |
Training of Pieter J. Strijkert
University of Utrecht | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Chiron Corp.
![]() Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
![]() Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Paratek Pharmaceuticals, Inc. operates as a pharmaceutical company that focuses on the discovery, development, and commercialization of medicines. The firm’s lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed for use as a first-line monotherapy for serious community-acquired bacterial infections where antibiotic resistance is of concern for treating physicians. The company was founded by Stuart B. Levy and Walter A. Gilbert on July 3, 1996 and is headquartered in Boston, MA. | Health Technology |
deVGen NV
![]() deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Health Technology |
Introgene BV | Health Technology |
Dynacorts Therapeutics BV
![]() Dynacorts Therapeutics BV Medical/Nursing ServicesHealth Services Dynacorts Therapeutics BV provides treatments for depression and anxiety disorder. The private company is based in Leidschendam, Netherlands. | Health Services |
Janssen Vaccines & Prevention BV
![]() Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Pieter J. Strijkert